MANNKIND CORP

MNKD · Nasdaq · SIC 2834: Pharmaceutical Preparations
282
SEC Filings

Business Summary

PART I Item 1. B usiness Unless the context requires otherwise, the words MannKind, we, Company, us and our refer to MannKind Corporation and its subsidiaries. We are a biopharmaceutical company dedicated to transforming chronic disease care through innovative, patient-centric solutions. Focused on cardiometabolic and orphan lung diseases, we develop and commercialize treatments that address serious unmet medical needs, including diabetes, pulmonary hypertension, and fluid overload in heart fail...

Next Earnings

Q2 FY2026 — expected 2026-08-15

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionMNKDdiscussed_in_filing Cybersecurity
topic_mentionMNKDdiscussed_in_filing Cybersecurity
topic_mentionMNKDdiscussed_in_filing Healthcare & Bio
topic_mentionMNKDdiscussed_in_filing Healthcare & Bio

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-02-262025-12-310001193125-26-073516EDGAR98K words
2025-02-262024-12-310000950170-25-027735EDGAR—
2024-02-272023-12-310000950170-24-021423EDGAR—
2023-02-232022-12-310001564590-23-002309EDGAR—
2022-02-242021-12-310001564590-22-006702EDGAR—
2021-02-252020-12-310001564590-21-008440EDGAR—
2020-02-252019-12-310001564590-20-006198EDGAR—
2019-02-262018-12-310001564590-19-004263EDGAR—
2018-02-272017-12-310001564590-18-003510EDGAR—
2017-03-162016-12-310001193125-17-085519EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-052025-09-300001193125-25-265813EDGAR68K words
2025-08-062025-06-300000950170-25-103535EDGAR—
2025-05-082025-03-310000950170-25-066429EDGAR—
2024-11-072024-09-300000950170-24-123296EDGAR—
2024-08-072024-06-300000950170-24-092288EDGAR—
2024-05-082024-03-310000950170-24-055661EDGAR—
2023-11-072023-09-300000950170-23-060253EDGAR—
2023-08-072023-06-300000950170-23-039074EDGAR—
2023-05-092023-03-310000950170-23-019668EDGAR—
2022-11-082022-09-300001564590-22-036933EDGAR—
2022-08-092022-06-300001564590-22-028753EDGAR—
2022-05-052022-03-310001564590-22-018245EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-02-260001193125-26-073509EDGAR5K words
2025-11-100001193125-25-273321EDGAR—
2025-11-050001193125-25-265810EDGAR—
2025-10-090001193125-25-236064EDGAR—
2025-08-270000950170-25-111586EDGAR—
2025-08-250001193125-25-186994EDGAR—
2025-08-060000950170-25-103532EDGAR—
2025-05-190000950170-25-074523EDGAR—
2025-05-150001193125-25-120797EDGAR—
2025-05-080000950170-25-066426EDGAR—

282 total filings indexed. 250 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA ADIL — ADIAL PHARMACEUTICALS, INC.

Company Identity

CIK0000899460
TickerMNKD
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedDE

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: 518e55ef43a850e7fd2641999723b81c850914c70ba5f8828ea27da8b3821d70
parent: 06d2cb181d6278b122e3068174c1c1fd1fbe292788ba95447f127433c12b15be
content hash: ca4db5cb2aa93c6a0d64a6118ed6304956008ef23bdbce89da1c265ce3b311f3
signed: 2026-04-13T04:46:18.668Z
sources: 22 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf